1. Composite Endpoints for Clinical Trials

   • Peter Kleist

   Current Opinion 24 August 2012 Pages: 187 - 198

   

2. Biosimilars

   • Martin K. Kuhlmann
   • David Goldsmith
   • Adrian Covic

   Leading Article 24 August 2012 Pages: 199 - 206

   

3. Immunogenicity Issues in the Development of Therapeutic Proteins

   • Steven J. Swanson

   Review Article 24 August 2012 Pages: 207 - 216

   

4. Development of Tracer-Based Metabolomics and its Implications for the Pharmaceutical Industry

   • Greg Maguire
   • Laszlo Boros
   • Paul Lee

   Review Article 24 August 2012 Pages: 217 - 224

   

5. The Utility of Active-Controlled Noninferiority/Equivalence Trials in Drug Development

   • Yi Tsong

   Review Article 24 August 2012 Pages: 225 - 233

   

6. The 2006 Adrian Salter Lecture

   • Alasdair Breckenridge

   Meeting Report 24 August 2012 Pages: 235 - 237

7. Forum

   Update 24 August 2012 Pages: 239 - 242

8. Journal Watch

   Update 24 August 2012 Pages: 243 - 248

9. Major Pharmaceutical Conferences

   Update 24 August 2012 Pages: 249 - 250

   

10. Society of Pharmaceutical Meclicine

    SPM News 24 August 2012 Pages: 251 - 251